Are you searching for effective medications to treat 'Amyotrophic Lateral Sclerosis (ALS)'? This comprehensive guide provides the latest information on medications-both generic and branded-that ...

Treatment with IV edaravone for ALS was linked to a slowing of disease-progression milestones compared with no IV edaravone ...

LEXINGTON, Mass. - Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology firm focused on neurogenetic medicines with a market capitalization of $290 million, announced today it is reassessing its ...

A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.

Todd Demeule can no longer walk on his own. Also read: FDA advisers vote against experimental ALS treatment pushed by patients It all started when he fell. "Couple days later, I just wasn't ...

Individuals living with ALS are automatically eligible for Medicare when they start receiving Social Security benefits. Medicare should cover most diagnostics and treatments, but this depends on the ...

Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...

A new analysis of an overall survival study of an investigational immunotherapy platform to treat ALS found it slowed disease progression and extended survival, according to the manufacturer.In a ...

CORESTEM is a biotechnology company specializing in the research and development of personalized stem cell therapies for neurological and autoimmune diseases. Its lead product is NeuroNata-R ...

An announcement from Neurosense Therapeutics Ltd. ( (NRSN) ) is now available.